Literature DB >> 21732793

Molecular characteristics of HIV type 1 infection among prisoners from Central Western Brazil.

Ludimila Paula Vaz Cardoso1, Alexsander Augusto da Silveira, Roberta Barbosa Lopes Francisco, Mônica Nogueira da Guarda Reis, Mariane Martins de Araújo Stefani.   

Abstract

Abstract This study among antiretroviral-experienced prisoners from central western Brazil investigated mutations associated with secondary resistance to nucleoside/nonnucleoside reverse transcriptase inhibitors (NRTI/NNRTI), protease inhibitors (Stanford HIV-1 Resistance/International Aids Society Databases), and HIV-1 subtypes (REGA/phylogenetic analyses/SimPlot). Twenty-seven prisoners from three prisons (16 males and four females from Mato Grosso do Sul State and seven males from Goiás State) had HIV-1 protease and reverse transcriptase fragments sequenced after nested PCR. Median age was 35 years. Seven males and two females were intravenous drug users, three males referred homosexual practice. Resistance mutations were present in 37% (10/27): NRTI+NNRTI mutations (n=5), NRTI mutations (n=3), multidrug-resistant mutations (n=2). Subtype B (48%), subtype C (11%), B/F1, B/C, and F1/B/C recombinants (40.7%) were detected. Possible intraprison transmissions were identified: two intravenous drug user females (subtype C); two clusters among homosexual males (subtype B and B/F1). High resistance rate and possible intraprison transmission highlight the need for improved prevention, counseling, and treatment strategies for prisoners.

Entities:  

Mesh:

Year:  2011        PMID: 21732793      PMCID: PMC3227242          DOI: 10.1089/aid.2011.0153

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  15 in total

1.  Completing the molecular investigation into the HIV outbreak at Glenochil prison.

Authors:  D L Yirrell; S J Hutchinson; M Griffin; S M Gore; A J Leigh-Brown; D J Goldberg
Journal:  Epidemiol Infect       Date:  1999-10       Impact factor: 2.451

2.  Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey.

Authors:  J Long; S Allwright; J Barry; S R Reynolds; L Thornton; F Bradley; J V Parry
Journal:  BMJ       Date:  2001-11-24

3.  The vulnerability of Brazilian female prisoners to HIV infection.

Authors:  L Strazza; R S Azevedo; H B Carvalho; E Massad
Journal:  Braz J Med Biol Res       Date:  2004-04-22       Impact factor: 2.590

4.  An automated genotyping system for analysis of HIV-1 and other microbial sequences.

Authors:  Tulio de Oliveira; Koen Deforche; Sharon Cassol; Mika Salminen; Dimitris Paraskevis; Chris Seebregts; Joe Snoeck; Estrelita Janse van Rensburg; Annemarie M J Wensing; David A van de Vijver; Charles A Boucher; Ricardo Camacho; Anne-Mieke Vandamme
Journal:  Bioinformatics       Date:  2005-08-02       Impact factor: 6.937

5.  Identification of two new CRF_BF in Rio de Janeiro State, Brazil.

Authors:  Monick L Guimarães; Walter A Eyer-Silva; José C Couto-Fernandez; Mariza G Morgado
Journal:  AIDS       Date:  2008-01-30       Impact factor: 4.177

6.  HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.

Authors:  Ludimila Paula Vaz Cardoso; Boaventura Braz de Queiroz; Mariane Martins de Araújo Stefani
Journal:  J Clin Virol       Date:  2009-08-13       Impact factor: 3.168

7.  Molecular investigation into outbreak of HIV in a Scottish prison.

Authors:  D L Yirrell; P Robertson; D J Goldberg; J McMenamin; S Cameron; A J Leigh Brown
Journal:  BMJ       Date:  1997-05-17

8.  Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.

Authors:  K S Lole; R C Bollinger; R S Paranjape; D Gadkari; S S Kulkarni; N G Novak; R Ingersoll; H W Sheppard; S C Ray
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Molecular screening shows extensive HIV-1 genetic diversity in Central West Brazil.

Authors:  Mariane M A Stefani; Gisner A S Pereira; Janaina A B Lins; Keila C Alcantara; Alexsander A Silveira; Angela A Viegas; Nadia C Maya; Aparecida Hg Mussi
Journal:  J Clin Virol       Date:  2007-05-29       Impact factor: 3.168

10.  HIV infection and risk factors among Bangkok prisoners, Thailand: a prospective cohort study.

Authors:  Hansa Thaisri; John Lerwitworapong; Suthon Vongsheree; Pathom Sawanpanyalert; Chanchai Chadbanchachai; Archawin Rojanawiwat; Wichuda Kongpromsook; Wiroj Paungtubtim; Pongnuwat Sri-ngam; Rachaneekorn Jaisue
Journal:  BMC Infect Dis       Date:  2003-10-28       Impact factor: 3.090

View more
  8 in total

1.  Combined antiretroviral and anti-tuberculosis drug resistance following incarceration.

Authors:  K E Stott; T de Oliviera; R J Lessells
Journal:  South Afr J HIV Med       Date:  2013-09-01       Impact factor: 2.744

2.  Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions.

Authors:  Mônica Nogueira da Guarda Reis; Gonzalo Bello; Monick Lindenmeyer Guimarães; Mariane Martins Araújo Stefani
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

3.  HIV Drug Resistance and Transmission Networks Among a Justice-Involved Population at the Time of Community Reentry in Washington, D.C.

Authors:  Curt G Beckwith; Sugi Min; Akarsh Manne; Vladimir Novitsky; Mark Howison; Tao Liu; Irene Kuo; Ann Kurth; Lauri Bazerman; Anya Agopian; Rami Kantor
Journal:  AIDS Res Hum Retroviruses       Date:  2021-05-24       Impact factor: 1.723

4.  Molecular Epidemiology of HIV-1 among Prisoners in Central Brazil and Evidence of Transmission Clusters.

Authors:  Tayana Serpa Ortiz Tanaka; Gabriela Alves Cesar; Grazielli Rocha de Rezende; Marco Antonio Moreira Puga; Sabrina Moreira Dos Santos Weis-Torres; Larissa Melo Bandeira; Maurício Antônio Pompílio; Julio Croda; Monick Lindenmeyer Guimarães; Ana Rita Coimbra Motta-Castro
Journal:  Viruses       Date:  2022-07-28       Impact factor: 5.818

5.  HIV behind bars: human immunodeficiency virus cluster analysis and drug resistance in a reference correctional unit from southern Brazil.

Authors:  Isabel M Prellwitz; Brunna M Alves; Maria Letícia R Ikeda; Daniele Kuhleis; Pedro D Picon; Carla A Jarczewski; Marta R Osório; Alexandra Sánchez; Héctor N Seuánez; Bernard Larouzé; Marcelo A Soares; Esmeralda A Soares
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

6.  Tracing the origin and northward dissemination dynamics of HIV-1 subtype C in Brazil.

Authors:  Edson Delatorre; José C Couto-Fernandez; Monick Lindenmayer Guimarães; Ludimila Paula Vaz Cardoso; Keila Correia de Alcantara; Mariane Martins de Araújo Stefani; Hector Romero; Caio C M Freire; Atila Iamarino; Paolo M de A Zanotto; Mariza G Morgado; Gonzalo Bello
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

7.  HIV-1 infection among crack cocaine users in a region far from the epicenter of the HIV epidemic in Brazil: Prevalence and molecular characteristics.

Authors:  Divânia Dias da Silva França; Nativa Helena Alves Del-Rios; Megmar Aparecida Dos Santos Carneiro; Rafael Alves Guimarães; Karlla Antonieta Amorim Caetano; Monica Nogueira da Guarda Reis; Regina Maria Bringel Martins; Ana Rita Coimbra Motta-Castro; Mariane Martins de Araujo Stefani; Sheila Araujo Teles
Journal:  PLoS One       Date:  2018-07-17       Impact factor: 3.240

8.  Human immunodeficiency virus infection and syphilis among homeless people in a large city of Central-Western Brazil: prevalence, risk factors, human immunodeficiency virus-1 genetic diversity, and drug resistance mutations.

Authors:  Raquel Silva Pinheiro; Paulie Marcelly Ribeiro Dos Santos Carvalho; Marcos André de Matos; Karlla Antonieta Amorim Caetano; Andressa Cunha de Paula; Megmar Aparecida Dos Santos Carneiro; Mônica Nogueira da Guarda Reis; Regina Maria Bringel Martins; Mariane Martins de Araújo Stefani; Sheila Araujo Teles
Journal:  Braz J Infect Dis       Date:  2020-11-25       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.